Delivery Order SPE2DB22D3501-SPE2DB24FUS09
Award Date 2/26/24
Potential Completion Date 2/27/24
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D2007|SPE2DB24FJ1MD) worth $1,257.04 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a potential value of $2,194.16 and a completion date of January 26, 2024. This award does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The delivery order, valued at $1,097.08, has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a completion date of February 1, 2024 and a potential value of $1,524.22. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a maximum value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $6,533.36, to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The potential value of this contract is $5,623.10 and the period of performance runs through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This award is under an existing indefinite delivery...
- The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $2,662.44 and a performance period ending on April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,156.46 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...